BioNTech Q2 EPS €(0.79) Down From €6.45 YoY, Sales €167.70M Down From €3.20B YoY
Portfolio Pulse from Benzinga Newsdesk
BioNTech reported Q2 losses of €(0.79) per share, a 112.25% decrease YoY. Sales also decreased by 94.75% to €167.70M from €3.20B YoY.
August 07, 2023 | 10:08 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
BioNTech's Q2 earnings and sales significantly decreased YoY.
BioNTech's Q2 earnings and sales have significantly decreased compared to the same period last year. This could negatively impact investor sentiment and the company's stock price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100